Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

<< Previous
Bullboard Posts
Next >>
Post by lscfaon Jun 05, 2024 9:07am
166 Views
Post# 36072827

June 6 delist

June 6 delist

CEAPRO INC. ("CZO")
BULLETIN TYPE: Plan of Arrangement, Remain Halted, Delist
BULLETIN DATE: June 4, 2024
TSX Venture Tier 2 Company 

TSX Venture Exchange (the "Exchange") has accepted for filing documentation in connection with an arrangement agreement dated December 14, 2023, as amended on January 16, 2024, between Ceapro Inc. ("Ceapro") and Aeterna Zentaris Inc. ("Aeterna"), pursuant to which Aeterna acquired all of the issued and outstanding common shares of Ceapro by way of a plan of arrangement under the Canada Business Corporations Act (the "Arrangement"). Under the terms of the Arrangement, Ceapro shareholders received 0.02360 of an Aeterna share for each Ceapro share held. The transaction also provided that all outstanding options of Ceapro were exchanged into securities of Aeterna in accordance with the terms of the Arrangement.

The Exchange has been advised that the requisite approval of the Arrangement by Ceapro shareholders was received at a special meeting of shareholders held on March 12, 2024, and that the Court of King's Bench of Alberta granted a final order with respect to the Arrangement on March 28, 2024. The Arrangement was completed on June 3, 2024.

Delisting: 

Effective at the close of business on Thursday, June 6, 2024, the common shares of Ceapro will be delisted from the TSX Venture Exchange.

For further details, please refer to management information circulars dated March 12, 2024, and filed by Aeterna and Ceapro which are available under each company's profile on SEDAR+, and Ceapro's news releases dated December 14, 2023February 15, 2024February 23, 2024February 26, 2024March 12, 2024March 28, 2024May 17, 2024, and June 3, 2024.

 
<< Previous
Bullboard Posts
Next >>